Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo

Gene Therapy

Volumn 7, Issue 15, 2000, Pages 1326-1332

  Tomita, N ^a,b   Morishita, R ^a,c   Tomita, S ^a,b   Gibbons, G H ^b   Zhang, L ^b   Horiuchi, M ^b,d   Kaneda, Y ^c   Higaki, J ^a   Ogihara, T ^a   Dzau, V J ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Glomerulonephritis; HVJ liposome; Oligonucleotide; transcription factor decoy (TFD)

Indexed keywords

CD45 ANTIGEN; CELL ADHESION MOLECULE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOSOME; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; GLOMERULONEPHRITIS; GLOMERULUS; IN VIVO STUDY; INFLAMMATION; KIDNEY; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM REPEAT;

ANIMALIA; FELIS CATUS; GLOMERULUS; HUMAN PARAINFLUENZA VIRUS 1;

EID: 0033899541     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301243     Document Type: Article

References (38)

1. Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases
2. Cytokines, mesangial cell activation and glomerular injury
3. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
4. Platelet-derived growth factor and proliferative glomerulonephritis
5. ICAM-1 expression in renal disease
6. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo
7. Cytokines and mesangial cells
8. NF-kappa B: A pleitropic mediator of inducible and tissue specific gene control
9. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor
10. Activation of attenuattion of transcriptional factor NF-κB in mouse glomerular cells in response to tumor necrosis factor-, immunoglobulin G, and adenosis 3'-5'-cyclic monophosphate
11. Functional analysis of the human vascular cell adhesion molecule 1 promoter
12. Mesangial cell accessory functions: Mediation by intracellular adhesion molecule-1
13. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides
14. Overexpression of TAR sequence renders cells resistant to human immunodeficiency virus replication
15. A novel molecular strategy using cis element 'decoy' of E2F binding site inhibits smooth muscle proliferation in vivo
16. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer
17. A novel strategy transcription factor decoy for E2F inhibits proliferation in mesangial cells in vitro
18. Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo
19. Direct in vivo gene introduction into rat kidney
20. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor into the rat kidney
21. A cDNA encoding a RB-binding protein with properties of the transcription factor E2F
22. Expression cloning of a cDNA encoding a retinobalstoma-binding protein with E2F-like properties
23. Gene transfer into the mammalian kidney: First steps towards renal gene therapy
24. Adenoviral-mediated gene transfer to renal tubular cells in vivo
25. Single intraluminal delivery of antisense cdc 2 kinase and PCNA oligonucleotides results in chronic inhibition of neointimal hyperplasia
26. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides
27. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall: Enhanced therapeutic utility for restenosis by HVJ-liposome method
28. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen
29. Systemic administration of HVJ viral coat-liposome complex containing insulin vector decreases glucose level in diabetic mice: Model of gene therapy
30. Apolipoprotein E deficient mice created by systemic administration of antisense oligonucleotides: A new model for lipoprotein metabolism study
31. Induction of interleukin 6 synthesis in mouse glomeruli and cultured mesangial cells
32. Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP
33. Distinct nuclear proteins competing for an overlapping sequence of cAMP and negative-regulatory elements regulate tissue-specific mouse renin gene expression
34. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
35. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
36. Fusigenic viral liposome for gene therapy in cardiovascular diseases
37. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome
38. Cloning and sequencing of mouse VCAM-1 cDNA